ConductScience.org, home

Paper36588289

The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.

Nilsen DWT and 9 others. Thromb Haemost, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. Papers, record 36588289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36588289

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.
PubMed
Journal
Thromb Haemost
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2023-04-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nilsen DWTDennis W Thttps://orcid.org/0000-0001-6142-6863
2Røysland MMichelle
3Ueland TThor
4Aukrust PPål
5Michelsen AEAnnika E
6Staines HHarry
7Barvik SStåle
8Kontny FFrederic
9Nordrehaug JEJan Erik
10Bonarjee VVSVernon V S

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary Artery DiseaseMajor topic
Non-ST Elevated Myocardial InfarctionMajor topic
Myocardial InfarctionMajor topic
Male
Humans
Receptor, PAR-1
Angiopoietin-2
E-Selectin
von Willebrand Factor
Endothelial Cells
Vascular Endothelial Growth Factor A
Biomarkers
Plasminogen Inactivators
Lactones
Platelet Aggregation Inhibitors
Treatment Outcome

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112163646Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12163646PubMed
218447380Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.J Med Chem2008https://conductscience.org/library/papers/18447380PubMed
324402559Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.Thromb Haemost2014https://conductscience.org/library/papers/24402559PubMed
421683251Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation.Methods Enzymol2011https://conductscience.org/library/papers/21683251PubMed
517068295Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton.Circ Res2006https://conductscience.org/library/papers/17068295PubMed
627941161Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.Clin Sci (Lond)2017https://conductscience.org/library/papers/27941161PubMed
79241752Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells.Thromb Haemost1997https://conductscience.org/library/papers/9241752PubMed
825954157Thrombin regulation of synaptic transmission and plasticity: implications for health and disease.Front Cell Neurosci2015https://conductscience.org/library/papers/25954157PubMed
924397894Regulation of lipoprotein lipase by Angptl4.Trends Endocrinol Metab2014https://conductscience.org/library/papers/24397894PubMed
1022077816Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.N Engl J Med2012https://conductscience.org/library/papers/22077816PubMed
117679406Selectins.J Clin Invest1993https://conductscience.org/library/papers/7679406PubMed
1212805069Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.Blood2003https://conductscience.org/library/papers/12805069PubMed
1321976669Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli.J Biol Chem2011https://conductscience.org/library/papers/21976669PubMed
1431108880Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.Cells2019https://conductscience.org/library/papers/31108880PubMed
1534237166Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome.J Intern Med2021https://conductscience.org/library/papers/34237166PubMed
161672265Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.Cell1991https://conductscience.org/library/papers/1672265PubMed
1724173241Role of Angptl4 in vascular permeability and inflammation.Inflamm Res2014https://conductscience.org/library/papers/24173241PubMed
1816102047Protease-activated receptors in hemostasis, thrombosis and vascular biology.J Thromb Haemost2005https://conductscience.org/library/papers/16102047PubMed
1926033474Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?Exp Neurol2015https://conductscience.org/library/papers/26033474PubMed
2015626732Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.Blood2005https://conductscience.org/library/papers/15626732PubMed

See all 38 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41686764Analysis and mining of adverse events associated with vorapaxar: A FAERS database-based study.PLoS One2026https://conductscience.org/library/papers/41686764PubMed
37477012Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice.Circ Heart Fail2023https://conductscience.org/library/papers/37477012PubMed
37176005Species Differences in Platelet Protease-Activated Receptors.Int J Mol Sci2023https://conductscience.org/library/papers/37176005PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36588289

GET https://conductscience.org/api/papers/v1/36588289/references?page=2